Professional Overview
John Applegate currently holds the position of Chief Financial Officer (CFO) at Zephyr AI, a rapidly growing healthcare technology company. Based in Cambridge, John Applegate brings over 25 years of experience in finance, strategy, accounting, capital formation, investor relations, and business development to his role at Zephyr AI.
Educational Background
- MBA from Harvard Business School
- Bachelor’s Degree in Economics from Northwestern University
Professional Experience
John Applegate’s career spans several high-profile roles in the biotechnology and healthcare sectors:
Zephyr AI
- Title: Chief Financial Officer
- Appointed: May 16, 2024
- Responsibilities: Overseeing the financial strategy and operations; contributing to business development and growth initiatives.
- Recent Achievement: Played a critical role in securing a $111 million Series A funding round.
Verge Genomics
- Title: Chief Financial Officer
- Notable Achievement: Secured a new round of equity financing and established a major strategic partnership with AstraZeneca.
Valo Health
- Title: Vice President of Accounting and Finance
- Impact: Participated in the senior leadership team that boosted the company valuation from seed stage to over $1 billion.
Biogen
- Title: Senior Director and Head of Finance for the Research and Development Organization
- Achievements:
- Supported major business transactions, including the $3.25 billion purchase of TYSABRI® rights from Elan Corporation.
- Managed critical alliances with prominent organizations such as Eisai Co. and Genentech.
Key Announcements and Activities
- May 16, 2024: Zephyr AI officially announced John Applegate as the new CFO.
- May 20, 2024: Further press releases highlighted his appointment and emphasized his substantial experience and strategic acumen.
- June 3, 2024: Zephyr AI’s representation at the ASCO annual meeting, where John Applegate highlighted the AI-guided predictor of PARP sensitivity, illustrating the company's commitment to innovative drug discovery.
Zephyr AI Overview
Zephyr AI is a healthcare company focused on using artificial intelligence to transform precision medicine, particularly in oncology and cardiometabolic diseases. The company is recognized for its substantial clinicogenomic datasets and leverages partnerships and proprietary data to drive scientific discovery and innovative treatments.
Relevant Insights
- LinkedIn Connection: John Applegate has over 500+ connections on LinkedIn, reflecting a strong professional network crucial for strategic partnerships and financing opportunities.
- Leadership Style: Described as a collaborative leader committed to innovation and growth, which aligns well with Zephyr AI’s mission to revolutionize precision medicine.
- Networking and Influence: Active in professional forums and discussions, indicating a proactive approach in shaping industry trends and networking.
John Applegate's extensive background in finance, strategic development, and leadership within high-growth biotechnology firms positions him as a pivotal figure in Zephyr AI's trajectory. His role is critical in steering the company through its next phase of growth, capitalizing on his rich experience and industry connections to help achieve Zephyr AI's ambitious goals.
